Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CFAP20DC divergent transcript (CFAP20DC-DT) is a putative long noncoding RNA transcribed near or antisense to the CFAP20 domain containing (CFAP20DC) gene locus on chromosome 3. Divergent transcripts like CFAP20DC-DT are a class of lncRNAs often co-expressed with nearby protein-coding genes, potentially involved in regulatory interactions influencing chromatin, transcription, or cellular differentiation. Current research does not support CFAP20DC-DT as a protein-coding entity or therapeutic target. No aliases, molecular classification categories, functions, or disease associations for it are included in major biological databases, and no drugs interact with it[2][7][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CFAP20 domain containing divergent transcript (CFAP20DC-DT).